aha_2025
AHA 2025
- LBS.01 Groundbreaking Trials in Cardiometabolic Therapeutics : DR10624, CTX310, Olezarsen, Vesalius-CV
- LBS.02 Dilemmas in antithrombotic therapy in AF care post procedures : Adapt-AF, Optima-AF, Closure-AF et Ocean trial.
- LBS.03 Cutting Edge Valve and Coronary Trials : Recovery, Ablation trial, Favor-IV QVAS et Top trial.
- LBS.04 Cardiometabolic and Lifestyle Interventions for AF : Dare-AF, Meta-AF et DECAF.
- LBS.07 Recipes for Success in Heart Failure : Poly-HF, Caviar, Food-HF, Surpass-CVOT
aha_2025.txt · Dernière modification : de clementbecle